Date: Jul 23, 2015 Source: Lowell Sun (
click here to go to the source)
WILMINGTON -- Implant Sciences Corp. said it has won its first major sale in the drug-detection market, selling 32 of its QS-B220 desktop explosives and drugs trace detectors across eight correctional facilities in Mexico.
The units, which are replacing competing systems, will be deployed for drug detection, Implant Sciences officials said in a statement.
Financial terms were not disclosed.
In a statement, Implant Sciences' marketing chief, Darryl Jones, said the correctional facilities cited his company's expertise in non-radiation technology.
"Our Mexican customer was particularly impressed that our system has proven, in market after market, to deliver the highest performance and the lowest total cost of ownership and operation," Jones said.
Headquartered on Research Drive, Implant Sciences offers two explosives trace detection systems -- the QS-B220 desktop version and the QS-B150 handheld device.
The company reported fiscal 2014 sales of $8.5 million.
Read more: http://www.lowellsun.com/latestnews/ci_28528446/implant-sciences-wins-drug-detection-pact-mexico#ixzz3h7C0KQjP
